- Medicines to Reduce Breast Cancer Risk
- Tamoxifen and raloxifene
- What are the risks in taking these drugs?
- How long should women take these drugs to lower breast cancer risk?
- Do these drugs have the same risks as post-menopausal hormone therapy?
- Who should consider taking a drug to reduce their breast cancer risk?
- Breast cancer risk assessment
- Weighing risks versus benefits
- Aromatase inhibitors
- Other compounds being studied
- What does all of this mean for you?
- To learn more
Other compounds being studied
Some other medicines, such as bexarotene, lovastatin, and deslorelin, are in early stage clinical trials for breast cancer chemoprevention. It is not yet clear how well they may work to reduce breast cancer.
A few dietary supplements are also being studied to look at their possible role in reducing breast cancer risk. These include grapeseed extract, folate, omega-3 fatty acids, and vitamins B6 and B12.
Other clinical trials are looking at breast cancer reduction as an unintended effect of drugs used for other reasons. (This is how raloxifene, used for osteoporosis, was found to be useful in breast cancer.) Drugs currently being researched include aspirin, other non-steroidal anti-inflammatory drugs (NSAIDs), bisphosphonates (drugs for osteoporosis), and statins (drugs used to lower cholesterol).
This type of research takes many years. It will probably be some time before meaningful results on any of these compounds are available.
Last Medical Review: 09/12/2011
Last Revised: 09/12/2011